MDR-TB At Highest Level Yet in 20 Countries

The fourth report of the WHO/International Union Against TB and Lung Disease Global Project on Anti-Tuberculosis Drug Resistance Surveillance found 20 locales where multi-drug resistant TB is at its highest level yet. The earlier studies were done in 1997, 2000, and 2004; 14 of the locales are former Soviet countries, while four others are in China, WHO reported yesterday. Multi-drug resistant TB (MDR-TB) means TB that is resistant to the two most powerful first-line drugs, isoniazid and rifampicin. The 142-page report is available at www.who.int/tb/publications/2008/drs_report4_26feb08.pdf.

The report is based on data collected between 2002 and 2006 on 90,000 TB patients in 81 countries. It says extensively drug-resistant tuberculosis (XDR-TB), which is virtually untreatable, has been recorded in 45 countries but warns that few countries are currently equipped to diagnose XDR-TB, so limited data on cases were available for the report. WHO now estimates there are nearly 500,000 new MDR-TB cases per year -- about 5 percent of 9 million new TB cases of all types. The highest rate was recorded in Baku, the capital of Azerbaijan, where 22.3 percent of all new TB cases were reported as multi-drug resistant.

"TB drug resistance needs a frontal assault. If countries and the international community fail to address it aggressively now, we will lose this battle," said Dr. Mario Raviglione, director of the WHO Stop TB Department. "In addition to specifically confronting drug-resistant TB and saving lives, programs worldwide must immediately improve their performance in diagnosing all TB cases rapidly and treating them until cured, which is the best way to prevent the development of drug resistance."

WHO estimates $4.8 billion is needed for overall TB control in low- and middle-income countries in 2008, with $1 billion for MDR-TB and XDR-TB. Only about half of the needed funding is in place, however.

Download Center

  • EHS Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - September 2021

    September 2021

    Featuring:

    • COMBUSTIBLE DUST
      Managing Combustible Dust and Risk Mitigation
    • PPE: CONSTRUCTION
      The Rising Popularity of Safety Helmets on the Jobsite
    • PPE: ELECTRICAL SAFETY
      Five Tips for a Successful Wear Trial
    • SAFETY & HEALTH
      Medical Surveillance Versus Medical Screening
    View This Issue